A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab in Stage IV Squamous Cell Lung Cancer

dbGaP FAQdbGaP Access Request Video Tutorial

Platforms

dbGaP

View in dbGaP

phs003412.v1.p1

APIs

Consent Codes

GRU

Focus / Diseases

Carcinoma, Non-Small-Cell Lung

Study Design

Interventional

Data Types

Unspecified

Subjects

160